A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)
Clinical trial NCT07753824 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07753824
- Sponsor
- M.D. Anderson Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-16
- Primary completion
- 2031-11-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.